OFI Advisors’s Zimmer Biomet ZBH Stock Holding History

OFI Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$372K	Buy	4,077 +177	+5%	+$17.7K	0.02%	876
2015 Q2	$414K	Buy	3,900 +304	+8%	+$33.6K	0.02%	874
2015 Q1	$410K	Buy	3,596 +92	+3%	+$10.5K	0.02%	860
2014 Q4	$386K	Sell	3,504 -100	-3%	-$10.5K	0.02%	853
2014 Q3	$352K	Buy	3,604 +121	+3%	+$11.9K	0.03%	838
2014 Q2	$351K	Sell	3,483 -119	-3%	-$11.6K	0.03%	858
2014 Q1	$331K	Buy	3,602 +98	+3%	+$9.03K	0.03%	826
2013 Q4	$317K	Buy	3,504 +16	+0.5%	+$1.39K	0.03%	818
2013 Q3	$278K	Sell	3,488 -105	-3%	-$8.27K	0.03%	771
2013 Q2	$261K	Buy	+3,593	New	+$269K	0.03%	711

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

OFI Advisors's ZBH Position: Q3 2015 in Review

OFI Advisors increased its Zimmer Biomet (ZBH) stake by 4.5% in Q3 2015, buying an estimated $17.7K and bringing the position to 4,077 shares worth $372K. The position accounts for 0.02% of the portfolio, ranked #876.

OFI Advisors first reported a position in ZBH in Q2 2013 and has held it in 10 quarters since. The position peaked at $414K in Q2 2015. 725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

OFI Advisors held 4,077 shares of Zimmer Biomet worth $372K as of Q3 2015.
OFI Advisors bought 177 Zimmer Biomet shares in Q3 2015, an estimated $17.7K.
Zimmer Biomet made up 0.02% of OFI Advisors's portfolio in Q3 2015, its #876 holding.
OFI Advisors first reported a position in Zimmer Biomet in Q2 2013 and has held it in 10 quarters since.
OFI Advisors's Zimmer Biomet position peaked at $414K in Q2 2015.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on OFI Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.